- Joined
- Dec 3, 2017
- Messages
- 26,290
- Reaction score
- 16,776
- Gender
- Male
- Political Leaning
- Progressive
Regeneron CEO: US manufacturing for coronavirus treatments, vaccines is 'limited' | TheHill
The CEO of Regeneron, a pharmaceutical company developing a coronavirus treatment, said the U.S. has limited capacity to manufacture potential COVID-19 treatments or vaccines.
Leonard Schleifer said Sunday on CNN’s “State of the Union” two aspects of health care infrastructure must be in place for when a vaccine or treatment becomes available: distribution and manufacturing.
“Our distribution capabilities work. I'm not worried about that,” he said. “Our manufacturing capacity, on the other hand...I think our capacity is limited.”
=============================================
I would think someone in this position has a good handle on this question. This again is an area where the WH & the DPA could be a big help. Something tells me that that is not going to happen.
The CEO of Regeneron, a pharmaceutical company developing a coronavirus treatment, said the U.S. has limited capacity to manufacture potential COVID-19 treatments or vaccines.
Leonard Schleifer said Sunday on CNN’s “State of the Union” two aspects of health care infrastructure must be in place for when a vaccine or treatment becomes available: distribution and manufacturing.
“Our distribution capabilities work. I'm not worried about that,” he said. “Our manufacturing capacity, on the other hand...I think our capacity is limited.”
=============================================
I would think someone in this position has a good handle on this question. This again is an area where the WH & the DPA could be a big help. Something tells me that that is not going to happen.